High NDRG3 expression facilitates HCC metastasis by promoting nuclear translocation of β-catenin
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
NDRG1 has been reported to exert pivotal roles in tumor progression and metastasis via Wnt/β-catenin signaling pathway. However, little is known about the role of NDRG3 in hepatocarcinogenesis despite its classification in the same subfamily of NDRG1. The present study was aimed to characterize the expression pattern and understand the biological roles of NDRG3 in hepatocarcinogenesis, as a means to exploit its therapeutic potential. It was observed that NDRG3 was up-regulated in HCC tissues and higher NDRG3 expression was associated with significantly shorter overall survival. Furthermore, a lower level of NDRG3 exhibited marked positive correlation with metastasis-free survival. In vitro and in vivo experiments revealed that knock-down of NDRG3 inhibits HCC metastasis and angiogenesis. We further demonstrated that activation of WNT/β-catenin signaling and enhanced CSC-like properties were responsible for NDRG3- mediated promoting effect on HCC. In conclusion, the principal findings demonstrated that high NDRG3 expression facilitates HCC metastasis via regulating the turnover of β-catenin, as well as provides a potential therapeutic target for future therapeutic interventions.
Abstract
NDRG1 has been reported to exert pivotal roles in tumor progression and metastasis via Wnt/β-catenin signaling pathway. However, little is known about the role of NDRG3 in hepatocarcinogenesis despite its classification in the same subfamily of NDRG1. The present study was aimed to characterize the expression pattern and understand the biological roles of NDRG3 in hepatocarcinogenesis, as a means to exploit its therapeutic potential. It was observed that NDRG3 was up-regulated in HCC tissues and higher NDRG3 expression was associated with significantly shorter overall survival. Furthermore, a lower level of NDRG3 exhibited marked positive correlation with metastasis-free survival. In vitro and in vivo experiments revealed that knock-down of NDRG3 inhibits HCC metastasis and angiogenesis. We further demonstrated that activation of WNT/β-catenin signaling and enhanced CSC-like properties were responsible for NDRG3- mediated promoting effect on HCC. In conclusion, the principal findings demonstrated that high NDRG3 expression facilitates HCC metastasis via regulating the turnover of β-catenin, as well as provides a potential therapeutic target for future therapeutic interventions.
참고문헌 (32)
- Altekruse SF, "Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States", Am J Gastroenterol, 109, pp.542~553 (2014)
- Kim SR, "Epidemiology of hepatocellular carcinoma in Japan and Korea. A review", Oncology, 75(Suppl 1), pp.13~16 (2008)
- Zhu AX, "Systemic treatment of hepatocellular carcinoma: dawn of a new era?", Ann Surg Oncol, 17, pp.1247~1256 (2010)
- Okuda T, "Identification of new genes ndr2 and ndr3 which are related to Ndr1", RTP, Biochem Biophys Res Commun, pp.1999, 266[DOI]
- Zhao W, "Cloning and expression pattern of the human NDRG3 gene", Biochim Biophys Acta, 1519, pp.134~138 (2001)
- Shimono A, "N-mycdependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant", Mech Dev, 83, pp.39~52 (1999)
- Zhou RH, "Characterization of the human NDRG gene family : a newly identified member, NDRG4, is specifically expressed in brain and heart", Genomics, 73, pp.86~97 (2001)
- Qu X, "Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family", Mol Cell Biochem, 229, pp.35~44 (2002)
- Melotte V, "The N-myc downstream regulated gene(NDRG)family : diverse functions, multiple applications", FASEB J, 24, pp.4153~4166 (2010)
- Ulrix W, "The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells", FEBS Lett, 455, pp.23~26 (1999)
- Lee GY, "Potential role of the N-MYC downstream-regulated gene family in reprogramming cancer metabolism under hypoxia", Oncotarget, 7, pp.57442~57451 (2016)
- Bandyopadhyay S, "The Drg-1 gene suppresses tumor metastasis in prostate cancer", Cancer Res, 63, pp.1731~1736 (2003)
- Guan RJ, "Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer", Cancer Res, 60, pp.749~755 (2000)
- Stein S, "NDRG1 is necessary for p53-dependent apoptosis", J Biol Chem, 279, pp.48930~48940 (2004)
- Lu WJ, "NDRG1promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3ОІ and Nur77 to prevent ОІ-catenin degradation", Oncotarget, 6, pp.29847~29859 (2015)
- Mitchelmore C, "NDRG2 : a novel Alzheimer's disease associated protein", Neurobiol Dis, 16, pp.48~58 (2004)
- Deng Y, "N-Myc downstream-regulated gene 2(NDRG2)inhibits glioblastoma cell proliferation", Int J Cancer, 106, pp.342~347 (2003)
- Kim YJ, "NDRG2 suppresses cell proliferation through down-regulation of AP-1 activity in human colon carcinoma cells", Int J Cancer, 124, pp.7~15 (2009)
- Melotte V, "N-Myc downstream-regulated gene 4(NDRG4) : a candidate tumor suppressor gene and potential biomarker for colorectal cancer", J Natl Cancer Inst, 101, pp.916~927 (2009)
- Schilling SH, "NDRG4 is required for cell cycle progression and survival in glioblastoma cells", J Biol Chem, 284, pp.25160~25169 (2009)
- Yang Q, "Increased Expression of NDRG3 in Mouse Uterus During Embryo Implantation and in Mouse Endometrial Stromal Cells During In Vitro Decidualization", Reprod Sci, 25, pp.1197~1207 (2017)
- Okuda T, "Differential expression patterns of NDRG family proteins in the central nervous system", J Histochem Cytochem, 56, pp.175~182 (2008)
- Cui C, "Hypoxic postconditioning attenuates apoptosis via inactivation of adenosine A2a receptor through NDRG3-Raf-ERK pathway", Biochem Biophys Res Commun, 491, pp.277~284 (2017)
- Yao Y, "Let-7f Regulates the Hypoxic Response in Cerebral Ischemia by Targeting NDRG3", Neurochem Res, 42, pp.446~454 (2017)
- Luo X, "High expression of NDRG3 associates with unfavorable overall survival in non-small cell lung cancer", Cancer Biomark, 21, pp.461~469 (2017)
- Ma J, "High expression of NDRG3 associates with positive lymph node metastasis and unfavourable overall survival in laryngeal squamous cell carcinoma", Pathology, 48, pp.691~696 (2016)
- Estiar MA, "Clinical significance of NDRG3 in patients with breast cancer", Future Oncol, 13, pp.961~969 (2017)
- Liu W, "KAI1gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer", J Biol Chem, 286, pp.18949~18959 (2011)
- Liu W, "The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1", Oncotarget, 6, pp.8851~8874 (2015)
- Mi L, "The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer cells", Oncogene, 36, pp.4323~4335 (2017)
- Akiba J, "N-myc downstream regulated gene 1(NDRG1)", Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma, 1994, pp.20, 1329~1335
- Du Z, "MicroRNA31-NDRG3regulation axes are essential for hepatocellular carcinoma survival and drug resistance", Cancer Biomark, 19, pp.221~230 (2017)